CompanyDrug

Reforgene Medicine RM-001 Thalassemia Gene Editing

CompanyDrug

Walvax Biotech Launches Phase IIIb Trial for mRNA COVID-19 Vaccine

CompanyDrug

Guangdong Zhongsheng Initiates Phase III Study for RAY1216 in COVID-19

Company

Bloomage Biotech CEO Investigated Over Discounted Share Sales

Policy / Regulatory

NMPA Proposes ‘Drug Online Sales Blacklist’ for Public Feedback

CompanyDrug

Ascentage Pharma Announces Clinical Advances for Olverembatinib at ASH

CompanyDrug

Abbisko Enrolls First Patient in Phase II Study for ABSK091 in Urothelial Carcinoma

CompanyDrug

Blue Shield Pharma’s LD013 CAR-T Therapy Approved for Clinical Trials

CompanyDeals

Biomed Union Raises RMB 200M in Series B Round for Diagnostic Products

CompanyDeals

Yaguo Technology Secures Series A+ Funding for Airway Management Devices

CompanyDeals

Novatim Immune Therapeutics Raises RMB 500M in First Financing Round

CompanyDeals

Pulnovo Medical Raises ‘Tens of Millions’ in New Financing Round